Preventing HIV, STIs Through School-Based Programs

Although a positive impact on behavior change has been reported following the implementation of curriculum-based programs, there is a lack of clear evidence that school-based ...

HPV Infection in HIV Increases Cervical Cancer Risk

Women with HIV have an increased risk for persistent HPV infection, which frequently progresses to cervical cancer, and they should be warned of their increased ...

Pausing ART: Safety and Ethical Considerations

Dr Gianella Weibel talks with Dr Li and Dr Dubé, investigators of a new study from the AIDS Clinical Trials Group, which uses an intensively ...

Microbiome and HIV

The interactions between HIV, ART, human sexual behavior, and the gut microbiome are complex and sorting out these interactions will be important to design future ...

Increasing HIV Viral Suppression Rates Through Financial Incentives

Use of incentives makes the most sense with disadvantaged populations including homeless, drug users, and people in developing countries.

PrEP for Adolescents at Risk for HIV

Experts discuss new findings supporting the need for PrEP in adolescents and discuss the continued debate surrounding parental consent and other relevant issues.

Risk Factors of Neurocognitive Decline in HIV+ Individuals

The incidence of neurocognitive impairment is high in HIV-infected population, despite the introduction of combination antiretroviral therapy (CART).

Understanding Why Patients Discontinue ART and Increasing Adherence

Learn more about when stopping antiretroviral therapy (ART) may be necessary, why patients discontinue ART, predicting viral suppression, and predicting and encouraging adherence.
HIV/AIDS

Latest News

Worse Cognitive and Motor Outcomes for HIV-Infected, HIV-Exposed Children

Worse Cognitive and Motor Outcomes for HIV-Infected, HIV-Exposed Children

Study found that both HIV+ and HIV-exposed but uninfected children had worse developmental outcomes compared with HIV-unexposed and uninfected children.

Prognostic Value of Plasma JC Virus-DNA in Progressive Multifocal Leukoencephalopathy

Prognostic Value of Plasma JC Virus-DNA in Progressive Multifocal Leukoencephalopathy

Polyomavirus JC-DNA assessment in plasma samples might complement progressive multifocal leukoencephalopathy diagnosis, especially when cerebrospinal fluid (CSF) is unavailable or polyomavirus JC-DNA is not detectable in CSF.

Three-Drug Regimen for HIV Treatment in Adults, Pediatrics Approved

Three-Drug Regimen for HIV Treatment in Adults, Pediatrics Approved

The FDA has approved Symfi Lo as a complete regimen for the treatment of HIV-1 infection in adult and pediatric patients.

ED Screening Using Antigen-Antibody Tests Identify Previously Undiagnosed HIV

ED Screening Using Antigen-Antibody Tests Identify Previously Undiagnosed HIV

A study found that nontargeted screening using antigen-antibody tests identified previously undiagnosed HIV infection at a rate that exceeded the CDC screening threshold by severalfold.

Rilpivirine Dosing Information Updated for Pregnant Women With HIV

Rilpivirine Dosing Information Updated for Pregnant Women With HIV

The prescribing information for Edurant has been updated to include dosing recommendations for pregnant women.

No Difference in Aging-Related Brain Changes in Patients With Suppressed HIV

No Difference in Aging-Related Brain Changes in Patients With Suppressed HIV

No differences in brain structure or cognitive function were seen over the course of 2 years compared with closely matched HIV-negative control patients.

FDA: Drug Interactions Section Updated for Prezcobix

FDA: Drug Interactions Section Updated for Prezcobix

The FDA has updated labeling for Prezcobix with new drug interactions data.

Mortality in HIV-Infected Children Predicted by Urine TB Lipoarabinomannan

Mortality in HIV-Infected Children Predicted by Urine TB Lipoarabinomannan

Benefits of urine lipoarabinomannan include its rapid point-of-care platform, low cost, and readily accessible sample type.

CDC: HIV Testing Low Among US Adults

CDC: HIV Testing Low Among US Adults

Almost 40% of women and more than 50% of men aged 15 to 44 years had never been tested for HIV between 2011 and 2015.

Cancer Risk Increased for Older Patients Living With HIV

Cancer Risk Increased for Older Patients Living With HIV

Investigators assessed the impact of age and length of time with HIV infection on risk for developing cancer.

Feature Article

Vagus Nerve Stimulation May Improve HIV-Associated Depression

Vagus Nerve Stimulation May Improve HIV-Associated Depression

Transcutaneous vagus nerve stimulation could provide a safe alternative treatment in HIV-depression by targeting both depression and other comorbidities that can burden people living with HIV.

Bone Loss and Fracture Risk in Patients With HIV: What We Know So Far

Bone Loss and Fracture Risk in Patients With HIV: What We Know So Far

In addition to prevention measures, switching off the ARTs associated with bone loss and administering intravenous bisphosphonate, a bone resorption inhibitor, can be an effective strategy for preventing bone loss seen in HIV-infected individuals.

Aging With HIV: Expert Insights on Complications and Challenges

Aging With HIV: Expert Insights on Complications and Challenges

Three HIV experts provide their insights into aging-related challenges and complications faced by people living with HIV.

ART and PrEP: How Technological Advances Can Improve Adherence

ART and PrEP: How Technological Advances Can Improve Adherence

Several technological advances have been developed to improve adherence to antiretroviral and preexposure prophylaxis therapy.

Last Gift Study: A Participant's Perspective on End-of-Life HIV Research

Last Gift Study: A Participant's Perspective on End-of-Life HIV Research

Dr Sara Gianella Weibel talks with Anthony B, a patient with HIV and end-stage amyotrophic lateral sclerosis and the first participant enrolled in the "Last Gift" end-of-life study, about his experience as part of this new end-of-life model to study HIV persistence.

Last Gift Study: Community Perspective on End-of-Life HIV Research

Last Gift Study: Community Perspective on End-of-Life HIV Research

Dr Sara Gianella Weibel talks with Jeff Taylor, community activist and long-term HIV survivor, about a new end-of-life model to study HIV persistence.

Last Gift Study: End-of-Life HIV Research

Last Gift Study: End-of-Life HIV Research

Dr Sara Gianella Weibel talks with Dr Davey Smith, head of the Division of Infectious Disease at the University of California, San Diego, about a proposed new model to study HIV persistence, called the Last Gift study.

A Transgender Woman's Perspective on HIV Research, Prevention, and Care

A Transgender Woman's Perspective on HIV Research, Prevention, and Care

Dr Sara Gianella talks with Brooke Sullivan, a transgender woman and HIV activist, about ways to improve transgender individuals' involvement in HIV research.

PrEP in the Transgender Population: New Study to Examine Effects

PrEP in the Transgender Population: New Study to Examine Effects

Dr Sara Gianella talks with Dr Sheldon Morris, from the University of California San Diego AntiViral Research Center about an upcoming PrEP study in transgender people, including understanding HIV prevention in this population, uptake of PrEP, and adherence to treatment.

HIV Transmission Through Breastfeeding: New Review and Expert Interview

HIV Transmission Through Breastfeeding: New Review and Expert Interview

Mother-to-child HIV transmission rates are low in the presence of antiretroviral therapy but increase once ART stops at 6 months postpartum.

Slideshows

SIGN UP FOR FREE E-NEWSLETTERS